IKKβ inhibitors identification part II: Ligand and structure-based virtual screening

Title
IKKβ inhibitors identification part II: Ligand and structure-based virtual screening
Authors
샨티추현아조용서오광석이병호신계정배애님
Keywords
IkappaB kinase (IKK); IKKβ; Homology modeling; Virtual screening; Pharmacophore; Docking
Issue Date
2010-06
Publisher
Bioorganic & medicinal chemistry
Citation
VOL 18, NO 11, 3951-3960
Abstract
IκB kinase (IKK) is critical in proinflammatory cytokine-induced IκBα phosphorylation and subsequent activation of the nuclear transcription factor NF-κB complex. The activated NF-κB plays a major role in the pathogenesis of a number of human disorders, such as rheumatic and chronic inflammatory diseases. The inhibition of NF-κB activation by small molecule inhibitors that targets IKKβ may provide a pharmacological basis for interfering with these acute processes. To date, only three inhibitors have passed preclinical trials; on the other hand, identifying novel IKKβ inhibitors could evolve as potential candidates to meet the clinical requirements in the future. In the present work, we have employed a virtual screening (VS) method to identify novel compounds. The VS scheme is comprised of pharmacophore filtering and, subsequently, receptor based screening. The VS scheme was applied to the databases of 1.04 million compounds to identify three novel compounds that can inhibit the IKKβ at a micro molar range. Moreover, these compounds can be raised into a potential anti-inflammatory drug candidate after optimizing and passing several phases of clinical trials.
URI
http://pubs.kist.re.kr/handle/201004/41732
ISSN
0968-0896
Appears in Collections:
KIST Publication > Article
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE